drugset / Trial / NCT00005816
Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV kidney cancer.
Timeline
- Start
- 2000-02
- Primary completion
- —
- Completion
- 2002-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | therapeutic autologous dendritic cells | Vaccine | — | Intravenous |